IMPRINT

Pentoxifylline may be Potentially Harmful in the Treatment of Peripartum Cardiomyopathy

Olaf Forster*
Received Date: February 08, 2022 Accepted Date: March 08, 2022 Published Date: March 10, 2022

doi: 10.17303/jcvm.2022.8.102

Citation: Olaf Forster (2022) Pentoxifylline may be Potentially Harmful in the Treatment of Peripartum Cardiomyopathy. J Cardio Vasc Med 1: 1-10.

ABSTRACT FULL TEXT REFERENCES TABLES & FIGURES

Impressum

Verantwortlich:

Olaf Forster

Grazer Platz 4

12157 Berlin

Deutschland

Kontakt:

dr.olaf.forster@web.de

+49 (0) 8332 7100

* Affiliations: Department of Cardiology, Chris Hani Baragwanath Hospital, University of the Witwatersrand, PO Bertsham 2013, Johannesburg, South Africa

Corresponding Author: Olaf Forster, MD, Department of Cardiology, Chris Hani Baragwanath Hospital, University of the Witwatersrand, PO Bertsham, 2013, South Africa and Grazer Platz 4, 12157 Berlin, Germany, Email: dr.olaf.forster@web.de

PRIVACY IMPRINT

Pentoxifylline may be Potentially Harmful in the Treatment of Peripartum Cardiomyopathy

Olaf Forster*Received Date: February 08, 2022 Accepted Date: March 08, 2022 Published Date: March 10, 2022doi: 10.17303/jcvm.2022.8.102Citation: Olaf Forster (2022) Pentoxifylline may be Potentially Harmful in the Treatment of Peripartum Cardiomyopathy. J Cardio Vasc Med 1: 1-10.

Impressum

Olaf Forster*
Received Date: February 08, 2022 Accepted Date: March 08, 2022 Published Date: March 10, 2022

doi: 10.17303/jcvm.2022.8.102

Citation: Olaf Forster (2022) Pentoxifylline may be Potentially Harmful in the Treatment of Peripartum Cardiomyopathy. J Cardio Vasc Med 1: 1-10.